Company · ELAN (New York Stock Exchange)
Elanco Animal Health Inc
Pharmaceutical Preparations
Key figures
- Revenue, 2025
- $4.72B
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Institutional holders
- 520 at 30 Jun 2026 (518 the quarter before)
- SEC number
- 1739104
Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 27 Oct 2026
Latest filings
5 Aug 2026
8-K 8-K DATED AUGUST 5, 2026
5 Aug 2026
10-Q 10-Q FOR THE PERIOD ENDED JUNE 30, 2026
27 May 2026
8-K FORM 8-K
6 May 2026
10-Q 10-Q FOR THE PERIOD ENDED MARCH 31, 2026
6 May 2026
8-K 8-K DATED MAY 6, 2026
Source: SEC EDGAR
With a free account
A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.